CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- 4 Planned sale Chief Executive Officer sold 4,000 shares at $3.96 ($15,828)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 3,000 shares at $4.64 ($13,935)
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 1,818 shares at $2.75 ($5,000)
- 4 Open-market buy Chief Executive Officer bought 3,636 shares at $2.75 ($9,999)
- 4 Open-market buy Director bought 3,636 shares at $2.75 ($9,999)
- 4 Open-market buy Chief Financial Officer bought 17,500 shares at $2.75 ($48,125)
- 4 Open-market buy Director bought 9,090 shares at $2.75 ($24,998)
- 4 Open-market buy Director bought 3,636 shares at $2.75 ($9,999)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 17 · 328 filings